Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
PYPD compared with APRE: revenue, margins and what each company keeps, and the suppliers and customers both name
PYPD
PolyPid Ltd.
Change
Mkt cap
Revenue
Revenue
APRE
Aprea Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
PYPD
PolyPid Ltd.
vs
APRE
Aprea Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
PYPD
No earnings history for PYPD.
APRE
2 of 4 reports
Report
implied
realized
× implied
Q3 FY26
—
▼
−1.90%
—
Q2 FY26
—
▲
+3.47%
—
= implied
PYPD realized, solid
APRE realized, hatched
One scale, both sides: full bar = 4%
× = |realized| ÷ implied
Source: market data
PYPD
PolyPid Ltd.
Change
5.63
▼
−3.26%
Mkt cap
$89.3M
Revenue
—
Revenue
—
APRE
Aprea Therapeutics, Inc.
Change
0.48
▼
−4.65%
Regular session
Nov 5 '26
Mkt cap
$7.2M
Revenue
$3,337
Q4 FY25
Revenue
$285,759
FY25
vs
Compare
Regular session
Nov 5 '26
PYPD
PolyPid Ltd.
vs
APRE
Aprea Therapeutics, Inc.
5.63
▼
−3.26%
Price
0.48
▼
−4.65%
$89.3M
Mkt cap
$7.2M
—
Revenue
$3,337
Q4 FY25
—
Revenue
$285,759
FY25
Change
Change
PYPD
5.63
▼
−3.26%
vs
APRE
0.48
▼
−4.65%
Regular session
Nov 5 '26